BioCorRx Inc. (BICX) Form 8-K — Sep 4, 2026

$BICXForm 8-KItems 5.02Filed Sep 4, 2026, 9:53 AM ET0001477932-26-005416Original filing

BioCorRx Inc. filed an 8-K reporting that board member Kate Beebe DeVarney, Ph.D. resigned from the board of directors effective August 31, 2026. The company stated the resignation did not arise as a result of any disagreement with BioCorRx or its subsidiary BioCorRx Pharmaceuticals.

AI analysis

Red flags1 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.